Pediatrix Medical Group, Inc.

MD Healthcare Medical Care Facilities

Pediatrix Medical Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, down 4.92% from fiscal 2024. In the quarter to June 2026, revenue grew 4.04%, EPS grew 6.52%, free cash flow fell 6.56% and total debt fell 3.84%, each against the same quarter a year earlier.

27.38 0.38 −1.37%
Market cap
$2.3B
P/E
13.1×
Fwd P/E
11.3×
Dividend yield
—
F-score
7/9
Altman Z
2.05
Beneish M
−2.86
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

8.82 11.03 10.38 12.12
P/S ratio
0.74 0.94 0.90 1.03
P/FCF ratio
5.18 7.12 7.29 8.80
P/Operating CF
10.32 15.76 (13.32) 16.06
P/B ratio
1.59 2.08 1.97 2.28
EV/Sales
0.81 0.99 1.03 1.12
EV/EBITDA
6.97 8.19 8.24 9.17
EV/FCF
5.69 7.51 8.39 9.59
Current Ratio
1.83 1.66 1.33 1.32
Net Debt/EBITDA
1.89 1.79 5.47 2.87
Debt/Equity
0.68 0.69 0.67 0.66
Earnings Yield
11.34% 9.07% 9.63% 8.25%
Free Cash Flow Yield
19.29% 14.05% 13.72% 11.36%
Free Cash Flow per Share
1.56 1.29 (1.68) 1.56
Book value per Share
10.53 10.30 10.86 11.09
Free Cash Flow
131.95 108.82 (136.09) 123.94
EV/EBIT
7.81 9.08 9.12 10.18
Other line items

Show all line items

Columns are period end dates